Access cutting-edge ovarian cancer treatment through this clinical trial at a research site in Atlanta. Study-provided care at no cost to qualified participants.
Access ovarian cancer specialists in Atlanta at no cost
This study follows strict safety protocols and ethical guidelines
All study-related ovarian cancer treatment provided free
The researchers are doing this study to find out whether the combination of avutometinib, defactinib, and letrozole is an effective treatment for people with low-grade serous ovarian cancer (LGSOC). The researchers will also look at the safety of this combination.
Sponsor: Memorial Sloan Kettering Cancer Center
Check if you qualify for this ovarian cancer clinical trial in Atlanta, GA
If you're searching for ovarian cancer treatment options in Atlanta, GA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Atlanta research site is actively enrolling participants for this clinical trial. You'll receive care from experienced ovarian cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.